History | Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts | Guidance | NICE

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 174 KB)

Published:

27 July 2016

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 378 KB)

Published:

23 June 2016
Committee papers (PDF 575 KB)

Published:

23 June 2016
Committee papers committee presentation (PDF 681 KB)

Published:

23 June 2016

Draft guidance

Draft guidance
Appraisal consultation document (PDF 390 KB)

Published:

08 April 2016
Committee papers (PDF 7.05 MB)

Published:

08 April 2016

Consultation documents published: Final Scope

Final scope (PDF 104 KB)

Published:

19 October 2015
NICE's response to comments on the draft scope and provisional matrix (PDF 247 KB)

Published:

19 October 2015
Equality impact assessment (Scoping) (PDF 123 KB)

Published:

19 October 2015
Final matrix (MSWord 77 KB)

Published:

22 October 2015

Draft scope documents

Draft scope (pre-referral) (PDF 111 KB)

Published:

07 October 2015
Provisional matrix (pre-referral) (PDF 102 KB)

Published:

07 October 2015